Chronic Transfusion Therapy Program: Focus on Sickle Cell Disease Course by NYBCe
Introduction:
Join New York Blood Center Enterprises (NYBCe) in the comprehensive course on chronic transfusion therapy for sickle cell disease. Authored by Nancy Van Buren, MD, and Kay Stephens, MT(ASCP)SH, this course delves into the etiology of sickle cell disease, transfusion options, transfusion complications, the American Society of Hematology guidelines, and the role of genotyping and antigen-matched blood in a chronic transfusion therapy program. Expand your knowledge at an intermediate level and earn 1.0 P.A.C.E. contact hours.
Section 1: Etiology of Sickle Cell Disease and Transfusion Options
Explore the etiology of sickle cell disease and the available transfusion options for its management. Gain insights into the following topics:
1.1 Understanding Sickle Cell Disease: Learn about the underlying causes and pathophysiology of sickle cell disease.
1.2 Transfusion Options: Explore the different transfusion strategies employed in the management of sickle cell disease, including chronic transfusion therapy.
Section 2: Transfusion Complications and ASH Guidelines
Discover the potential complications associated with transfusion therapy for sickle cell disease and the guidelines provided by the American Society of Hematology (ASH). This section covers:
2.1 Transfusion Complications: Understand the various risks and complications that may arise from transfusion therapy in individuals with sickle cell disease.
2.2 ASH Guidelines: Familiarize yourself with the 2020 guidelines from the American Society of Hematology for transfusion support in sickle cell disease, including indications, monitoring, and adverse event management.
Section 3: Role of Genotyping and Antigen-Matched Blood in Chronic Transfusion Therapy
Learn about the role of genotyping and antigen-matched blood in a chronic transfusion therapy program for sickle cell patients. This section includes:
3.1 Genotyping Considerations: Understand how genotyping can inform treatment decisions and assist in personalized management approaches for patients with sickle cell disease.
3.2 Antigen-Matched Blood: Explore the importance of matching blood products for specific antigens in transfusion therapy for sickle cell disease.
Conclusion:
Join in the comprehensive Chronic Transfusion Therapy Program for Sickle Cell Disease course authored by Nancy Van Buren, MD, and Kay Stephens, MT(ASCP)SH. Enhance your understanding of the etiology of sickle cell disease, transfusion options, transfusion complications, the American Society of Hematology guidelines, and the role of genotyping and antigen-matched blood in a chronic transfusion therapy program. Earn 1.0 P.A.C.E. contact hours while expanding your knowledge at an intermediate level.